Form 8-K - Current report:
SEC Accession No. 0001104659-24-086532
Filing Date
2024-08-07
Accepted
2024-08-07 07:08:07
Documents
15
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420943d1_8k.htm   iXBRL 8-K 26309
2 EXHIBIT 99.1 tm2420943d1_ex99-1.htm EX-99.1 92189
6 GRAPHIC tm2420943d1_ex99-1img001.jpg GRAPHIC 5697
  Complete submission text file 0001104659-24-086532.txt   315419

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aplt-20240807.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20240807_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20240807_pre.xml EX-101.PRE 22381
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2420943d1_8k_htm.xml XML 3770
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 241181401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)